<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>2183-6914</journal-id>
<journal-title><![CDATA[Revista Onconews]]></journal-title>
<abbrev-journal-title><![CDATA[Revista Onconews]]></abbrev-journal-title>
<issn>2183-6914</issn>
<publisher>
<publisher-name><![CDATA[Associação de Enfermagem Oncológica Portuguesa (AEOP)]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S2183-69142023000200006</article-id>
<article-id pub-id-type="doi">https//doi.org/10.31877/on.2023.47.01</article-id>
<title-group>
<article-title xml:lang="pt"><![CDATA[Abordagem da hiperidrose paraneoplásica em cuidados paliativos: revisão integrativa de literatura]]></article-title>
<article-title xml:lang="en"><![CDATA[Approach to paraneoplastic hyperhidrosis in palliative care: integrative literature review]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Ribeiro]]></surname>
<given-names><![CDATA[Sandra Eugénia]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Sousa]]></surname>
<given-names><![CDATA[Sara Inês Pinto]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Ferreira]]></surname>
<given-names><![CDATA[Sara Alexandra Moutinho]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Luis]]></surname>
<given-names><![CDATA[Michael Sapateiro]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,USF Aníbal Cunha - ACeS Porto Ocidental  ]]></institution>
<addr-line><![CDATA[Porto ]]></addr-line>
<country>Portugal</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,USF São João de Ovar - ACeS Baixo Vouga  ]]></institution>
<addr-line><![CDATA[Ovar ]]></addr-line>
<country>Portugal</country>
</aff>
<aff id="Af3">
<institution><![CDATA[,Instituto Português de Oncologia do Porto Francisco Gentil Serviço de Cuidados Paliativos ]]></institution>
<addr-line><![CDATA[Porto ]]></addr-line>
<country>Portugal</country>
</aff>
<pub-date pub-type="pub">
<day>30</day>
<month>12</month>
<year>2023</year>
</pub-date>
<pub-date pub-type="epub">
<day>30</day>
<month>12</month>
<year>2023</year>
</pub-date>
<numero>47</numero>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://scielo.pt/scielo.php?script=sci_arttext&amp;pid=S2183-69142023000200006&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.pt/scielo.php?script=sci_abstract&amp;pid=S2183-69142023000200006&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.pt/scielo.php?script=sci_pdf&amp;pid=S2183-69142023000200006&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="pt"><p><![CDATA[Resumo  Introdução:  A hiperidrose paraneoplásica constitui um desafio pela falta de consenso quanto à sua abordagem em cuidados paliativos. Este artigo pretende rever a evidência científica acerca da abordagem da hiperidrose paraneoplásica em doentes paliativos. Métodos: Realizou-se uma revisão integrativa com artigos da MEDLINE/Pubmed®, Cochrane, DARE®, BMJ EBM®, NICE®, CMAJ® e Bandolier, através dos termos MeSH &#8220;Sweating&#8221;, &#8220;Hyperhidrosis&#8221;, &#8220;Palliative Care&#8221; e &#8220;Palliative Medicine&#8221;. A evidência encontrada foi classificada de acordo com a Escala de Oxford. Resultados: Incluíram-se 13 artigos sobre a abordagem da hiperidrose paraneoplásica. As intervenções avaliadas nestes estudos incluíram o uso de tioridazina, talidomida, olanzapina, gabapentina, canabinóides, acupunctura e fitoterapia chinesa. Os resultados foram heterogéneos e não se encontrou evidência robusta que comprove o benefício inequívoco de uma abordagem em relação a outra. Conclusão: A evidência sobre a abordagem da hiperidrose paraneoplásica em cuidados paliativos é de qualidade fraca (Nível de evidência 4; Força de recomendação C).]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract  Introduction: Paraneoplastic hyperhidrosis presents as a challenge due to lack of consensus on its approach in palliative care. This article aims to review the scientific evidence on the approach to paraneoplastic hyperhidrosis in patients in palliative care. Methods: An integrative review was conducted by searching articles in MEDLINE/Pubmed®, Cochrane, DARE®, BMJ EBM®, NICE®, CMAJ® and Bandolier, using the MeSH terms &#8220;Sweating&#8221;, &#8220;Hyperhidrosis&#8221;, &#8220;Palliative Care&#8221;, and &#8220;Palliative Medicine&#8221;. Included studies were classified using the Oxford scale. Results: This review includes 13 articles on the therapeutic approach to paraneoplastic hyperhidrosis using the following interventions: thioridazine, thalidomide, olanzapine, gabapentin, cannabinoids, acupuncture and Chinese herbal medicine. We obtained heterogeneous results and no robust evidence exists that unequivocally demonstrates one approach is more beneficial than another.  Conclusions: The available evidence on the therapeutic approach to paraneoplastic hyperhidrosis in palliative care has low quality (Level of Evidence 4; Strength of Recommendation C).]]></p></abstract>
<kwd-group>
<kwd lng="pt"><![CDATA[Hipersudorese]]></kwd>
<kwd lng="pt"><![CDATA[Hiperidrose]]></kwd>
<kwd lng="pt"><![CDATA[Cuidados Paliativos]]></kwd>
<kwd lng="pt"><![CDATA[Medicina Paliativa]]></kwd>
<kwd lng="pt"><![CDATA[Cuidados de conforto]]></kwd>
<kwd lng="en"><![CDATA[Sweating]]></kwd>
<kwd lng="en"><![CDATA[Hyperhidrosis]]></kwd>
<kwd lng="en"><![CDATA[Palliative Care]]></kwd>
<kwd lng="en"><![CDATA[Palliative Medicine]]></kwd>
<kwd lng="en"><![CDATA[Hospice Care.]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Nawrocki]]></surname>
<given-names><![CDATA[S, Cha J.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The etiology, diagnosis, and management of hyperhidrosis: A comprehensive review: Therapeutic options.]]></article-title>
<source><![CDATA[Journal of the American Academy of Dermatology]]></source>
<year>2019</year>
<volume>81</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>669-80</page-range></nlm-citation>
</ref>
<ref id="B2">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mercadante]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Porzio]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Valle]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Fusco]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Aielli]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Adile]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Orphan symptoms in advanced cancer patients followed at home]]></article-title>
<source><![CDATA[Supportive Care in Cancer]]></source>
<year>2013</year>
<volume>21</volume>
<numero>12</numero>
<issue>12</issue>
<page-range>3525-8</page-range></nlm-citation>
</ref>
<ref id="B3">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Tsai]]></surname>
<given-names><![CDATA[JS]]></given-names>
</name>
<name>
<surname><![CDATA[Wu]]></surname>
<given-names><![CDATA[CH]]></given-names>
</name>
<name>
<surname><![CDATA[Chiu]]></surname>
<given-names><![CDATA[TY]]></given-names>
</name>
<name>
<surname><![CDATA[Chen]]></surname>
<given-names><![CDATA[CY]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Significance of Symptom Clustering in Palliative Care of Advanced Cancer Patients]]></article-title>
<source><![CDATA[Journal of Pain and Symptom Management]]></source>
<year>2010</year>
<volume>39</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>655-62</page-range></nlm-citation>
</ref>
<ref id="B4">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Grond]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Zech]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Diefenbach]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Bischoff]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Prevalence and pattern of symptoms in patients with cancer pain: A prospective evaluation of 1635 cancer patients referred to a pain clinic]]></article-title>
<source><![CDATA[Journal of Pain and Symptom Management]]></source>
<year>1994</year>
<volume>9</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>372-82</page-range></nlm-citation>
</ref>
<ref id="B5">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Tsai]]></surname>
<given-names><![CDATA[JS]]></given-names>
</name>
<name>
<surname><![CDATA[Wu]]></surname>
<given-names><![CDATA[CH]]></given-names>
</name>
<name>
<surname><![CDATA[Chiu]]></surname>
<given-names><![CDATA[TY]]></given-names>
</name>
<name>
<surname><![CDATA[Hu]]></surname>
<given-names><![CDATA[WY]]></given-names>
</name>
<name>
<surname><![CDATA[Chen]]></surname>
<given-names><![CDATA[CY]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Symptom patterns of advanced cancer patients in a palliative care unit]]></article-title>
<source><![CDATA[Palliative Medicine]]></source>
<year>2006</year>
<volume>20</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>617-22</page-range></nlm-citation>
</ref>
<ref id="B6">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Zhukovsky]]></surname>
<given-names><![CDATA[DS]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Fever and sweats in the patient with advanced cancer]]></article-title>
<source><![CDATA[Hematology/Oncology Clinics of North America]]></source>
<year>2002</year>
<volume>16</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>579-88</page-range></nlm-citation>
</ref>
<ref id="B7">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Zasowska-Nowak]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Cia&#322;kowska-Rysz]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Hyperhidrosis in palliative care patients]]></article-title>
<source><![CDATA[Medycyna Paliatywna/Palliative Medicine]]></source>
<year>2017</year>
<volume>9</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>79-83</page-range></nlm-citation>
</ref>
<ref id="B8">
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cherny]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Fallon]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Kaasa]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Portenoy]]></surname>
<given-names><![CDATA[RK]]></given-names>
</name>
<name>
<surname><![CDATA[Currow]]></surname>
<given-names><![CDATA[DC]]></given-names>
</name>
</person-group>
<source><![CDATA[Oxford Textbook of Palliative Medicine]]></source>
<year>2015</year>
<page-range>724-39</page-range><publisher-name><![CDATA[Oxford University Press]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B9">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Dalal]]></surname>
<given-names><![CDATA[S. Arthur]]></given-names>
</name>
<name>
<surname><![CDATA[JA]]></surname>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Overview of sweating in palliative care.]]></article-title>
<source><![CDATA[UpToDate]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B10">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Twycross]]></surname>
<given-names><![CDATA[R.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Sweating in advanced cancer]]></article-title>
<source><![CDATA[Advances in Palliative Medicine]]></source>
<year>2004</year>
<volume>3</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>179-88</page-range></nlm-citation>
</ref>
<ref id="B11">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Quigley]]></surname>
<given-names><![CDATA[CS]]></given-names>
</name>
<name>
<surname><![CDATA[Baines]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Descriptive epidemiology of sweating in a hospice population]]></article-title>
<source><![CDATA[Journal of Palliative Care]]></source>
<year>1997</year>
<volume>3</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>22-6</page-range></nlm-citation>
</ref>
<ref id="B12">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Regnard]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Use of low dose thioridazine to control sweating in advanced cancer]]></article-title>
<source><![CDATA[Palliative Medicine]]></source>
<year>1996</year>
<numero>10</numero>
<issue>10</issue>
<page-range>78-9</page-range></nlm-citation>
</ref>
<ref id="B13">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cowap]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Hardy]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Thioridazine in the management of cancer-related sweating]]></article-title>
<source><![CDATA[Journal of Pain and Symptom Management]]></source>
<year>1998</year>
<volume>15</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>266</page-range></nlm-citation>
</ref>
<ref id="B14">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Abbas]]></surname>
<given-names><![CDATA[SQ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Use of thioridazine in palliative care patients with troublesome sweating]]></article-title>
<source><![CDATA[Journal of Pain and Symptom Management]]></source>
<year>2004</year>
<volume>27</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>194-5</page-range></nlm-citation>
</ref>
<ref id="B15">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Deaner]]></surname>
<given-names><![CDATA[P.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Thalidomide for distressing night sweats in advanced malignant disease]]></article-title>
<source><![CDATA[Palliative Medicine]]></source>
<year>1998</year>
<volume>12</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>208-9</page-range></nlm-citation>
</ref>
<ref id="B16">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Calder]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Bruera]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Thalidomide for night sweats in patients with advanced cancer]]></article-title>
<source><![CDATA[Palliative Medicine]]></source>
<year>2000</year>
<volume>14</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>77-8</page-range></nlm-citation>
</ref>
<ref id="B17">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Deaner]]></surname>
<given-names><![CDATA[PB]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The use of thalidomide in the management of severe sweating in patients with advanced malignancy: trial report]]></article-title>
<source><![CDATA[Palliative Medicine]]></source>
<year>2000</year>
<volume>14</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>429-31</page-range></nlm-citation>
</ref>
<ref id="B18">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Zylicz]]></surname>
<given-names><![CDATA[Z]]></given-names>
</name>
<name>
<surname><![CDATA[Krajnik]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Flushing and Sweating in an Advanced Breast Cancer Patient Relieved By Olanzapine]]></article-title>
<source><![CDATA[Journal of Pain and Symptom Management]]></source>
<year>2003</year>
<volume>25</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>494-5</page-range></nlm-citation>
</ref>
<ref id="B19">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Porzio]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Aielli]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Verna]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Porto]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Aloisi]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Cannita]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Gabapentin in the treatment of severe sweating experienced by advanced cancer patients]]></article-title>
<source><![CDATA[Supportive Care in Cancer]]></source>
<year>2006</year>
<volume>14</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>389-91</page-range></nlm-citation>
</ref>
<ref id="B20">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Maida]]></surname>
<given-names><![CDATA[V.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Nabilone for the Treatment of Paraneoplastic Night Sweats: A Report of Four Cases]]></article-title>
<source><![CDATA[Journal of Palliative Medicine]]></source>
<year>2008</year>
<volume>11</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>929-34</page-range></nlm-citation>
</ref>
<ref id="B21">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Carr]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Vertelney]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Fronk]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Trieu]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Dronabinol for the Treatment of Paraneoplastic Night Sweats in Cancer Patients: A Report of Five Cases]]></article-title>
<source><![CDATA[Journal of Palliative Medicine]]></source>
<year>2019</year>
<volume>22</volume>
<numero>10</numero>
<issue>10</issue>
<page-range>1221-3</page-range></nlm-citation>
</ref>
<ref id="B22">
<nlm-citation citation-type="">
<collab>INFARMED</collab>
<source><![CDATA[Deliberação N.º11/CD/2019]]></source>
<year>2019</year>
</nlm-citation>
</ref>
<ref id="B23">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hallam]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Whale]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Acupuncture for the Treatment of Sweating Associated with Malignancy]]></article-title>
<source><![CDATA[Acupuncture in Medicine]]></source>
<year>2003</year>
<volume>21</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>155-6</page-range></nlm-citation>
</ref>
<ref id="B24">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Chiu]]></surname>
<given-names><![CDATA[SC]]></given-names>
</name>
<name>
<surname><![CDATA[Lai]]></surname>
<given-names><![CDATA[YL]]></given-names>
</name>
<name>
<surname><![CDATA[Chang]]></surname>
<given-names><![CDATA[HH]]></given-names>
</name>
<name>
<surname><![CDATA[Chang]]></surname>
<given-names><![CDATA[KH]]></given-names>
</name>
<name>
<surname><![CDATA[Chen]]></surname>
<given-names><![CDATA[ST]]></given-names>
</name>
<name>
<surname><![CDATA[Liao]]></surname>
<given-names><![CDATA[HF]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The therapeutic effect of modified Yu Ping Feng San on idiopathic sweating in end-stage cancer patients during hospice care]]></article-title>
<source><![CDATA[Phytotherapy Research]]></source>
<year>2009</year>
<volume>23</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>363-6</page-range></nlm-citation>
</ref>
<ref id="B25">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Huang]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Chang]]></surname>
<given-names><![CDATA[HH]]></given-names>
</name>
<name>
<surname><![CDATA[Chiu]]></surname>
<given-names><![CDATA[SC]]></given-names>
</name>
<name>
<surname><![CDATA[Lai]]></surname>
<given-names><![CDATA[YL]]></given-names>
</name>
<name>
<surname><![CDATA[Chen]]></surname>
<given-names><![CDATA[YJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Modified Dang Gui Liu Huang Tang Eases Sleep Sweats in Elderly Patients with Terminal Cancer]]></article-title>
<source><![CDATA[International Journal of Gerontology]]></source>
<year>2016</year>
<volume>10</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>96-9</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
